LWM
DMTK

Laidlaw Wealth Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Laidlaw Wealth Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,350
Closed -$323K – 278
2021
Q1 		$323K Buy
+6,350
New +$332K 0.11% 158

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Laidlaw Wealth Management's DMTK Position: Q2 2021 in Review

Laidlaw Wealth Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 6,350 shares — an estimated $323K sold.

Laidlaw Wealth Management first reported a position in DMTK in Q1 2021 and held it in 1 quarter. The position peaked at $323K in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Laidlaw Wealth Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Laidlaw Wealth Management sold 6,350 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $323K.
  • Laidlaw Wealth Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Laidlaw Wealth Management's DermTech, Inc. Common Stock position peaked at $323K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Laidlaw Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.